Literature DB >> 28805170

Perspectives of patients, close relatives, nurses, and physicians on end-of-life medication management.

Marianne K Dees1, Eric C T Geijteman2, Wim J M Dekkers1, Bregje A A Huisman3, Roberto S G M Perez3, Lia van Zuylen4, Agnes van der Heide2, Evert van Leeuwen1.   

Abstract

ABSTRACTObjective:Our aim was to gain insight into the perspectives of patients, close relatives, nurses, and physicians on medication management for patients with a life expectancy of less than 3 months.
METHOD: We conducted an empirical multicenter study with a qualitative approach, including in-depth interviews with patients, relatives, nurses, specialists, and general practitioners (GPs). We used the constant comparative method and ATLAS.ti (v. 7.1) software for our analysis.
RESULTS: Saturation occurred after 18 patient cases (76 interviews). Some 5 themes covering 18 categories were identified: (1) priorities in end-of-life care, such as symptom management and maintaining hope; (2) appropriate medication use, with attention to unnecessary medication and deprescription barriers; (3) roles in decision making, including physicians in the lead, relatives' advocacy, and pharmacists as suppliers; (4) organization and communication (e.g., transparency of tasks and end-of-life conversations); and (5) prerequisites about professional competence, accessibility and quality of medical records, and financial awareness. Patients, relatives, nurses, specialists, and GPs varied in their opinions about these themes. SIGNIFICANCE OF
RESULTS: This study adds to our in-depth understanding of the complex practice of end-of-life medication management. It provides knowledge about the diversity of the perspectives of patients, close relatives, nurses, and physicians regarding beliefs, attitudes, knowledge, skills, behavior, work setting, the health system, and cultural factors related to the matter. Our results might help to draw an interdisciplinary end-of-life medication management guide aimed at stimulating a multidisciplinary and patient-centered pharmacotherapeutic care approach.

Entities:  

Keywords:  Decision making; End-of-life care; Interdisciplinary communication; Patient preferences; Polypharmacy

Mesh:

Year:  2017        PMID: 28805170     DOI: 10.1017/S1478951517000761

Source DB:  PubMed          Journal:  Palliat Support Care        ISSN: 1478-9515


  6 in total

1.  Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: A systematic review.

Authors:  Shakti Shrestha; Arjun Poudel; Kathryn Steadman; Lisa Nissen
Journal:  Br J Clin Pharmacol       Date:  2019-12-12       Impact factor: 4.335

2.  Health care professionals' attitudes towards deprescribing in older patients with limited life expectancy: A systematic review.

Authors:  Carina Lundby; Trine Graabaek; Jesper Ryg; Jens Søndergaard; Anton Pottegård; Dorthe Susanne Nielsen
Journal:  Br J Clin Pharmacol       Date:  2019-02-27       Impact factor: 4.335

3.  Polypharmacy, chemotherapy receipt, and medication-related out-of-pocket costs at end of life among commercially insured adults with advanced cancer.

Authors:  Cara L McDermott; J Randall Curtis; Qin Sun; Catherine Fedorenko; Karma Kreizenbeck; Scott D Ramsey
Journal:  J Oncol Pharm Pract       Date:  2021-04-07       Impact factor: 1.416

4.  Role of nurses in medication management at the end of life: a qualitative interview study.

Authors:  Bregje A A Huisman; Eric C T Geijteman; Marianne K Dees; Noralie N Schonewille; Margriet Wieles; Lia van Zuylen; Karolina M Szadek; Agnes van der Heide
Journal:  BMC Palliat Care       Date:  2020-05-13       Impact factor: 3.234

5.  Deprescribing tool for use in older Australians with life-limiting illnesses and limited life expectancy: a modified-Delphi study protocol.

Authors:  Shakti Shrestha; Arjun Poudel; Kathryn J Steadman; Lisa M Nissen
Journal:  BMJ Open       Date:  2021-04-01       Impact factor: 2.692

Review 6.  Nurses' perspective on their involvement in decision-making about life-prolonging treatments: A quantitative survey study.

Authors:  Susanne A M Arends; Maureen Thodé; Anke J E De Veer; H Roeline W Pasman; Anneke L Francke; Irene P Jongerden
Journal:  J Adv Nurs       Date:  2022-03-21       Impact factor: 3.057

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.